PTK2 and melanoma: The rewiring of pathways involved in actin cytoskeleton-dependent invasiveness is also described in the work of [105], in which the SFKs–FAK–signal transducer and activator of transcription 3 (STAT3) signaling axis is activated after BRAFi or MEKi treatment, leading to an invasive phenotype of melanoma cells.